US Patent 12007394 Biomarker for prognosis of thyroid cancer
Patent 12007394 was granted and assigned to National Taiwan University on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+469 characters)
US Patent 12007394 Biomarker for prognosis of thyroid cancer
Article
Patent abstract
The present disclosure provides a method of prognosis of thyroid cancer including obtaining an exosome from a subject who had received a therapy of thyroid cancer such as thyroidectomy, and detecting whether thyroglobulin is present in the exosome. Moreover, the present disclosure provides the use of urinary exosomal thyroglobulin in being a non-invasive, reproducible, convenient, serial, and accurate follow-up marker for patient with thyroid cancer.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chih-Yuan Wang0
Pei-Jie Huang0
Tien-Chun Chang0
Date of Patent
June 11, 2024
0Patent Application Number
166381570
Date Filed
May 15, 2018
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12007394 Biomarker for prognosis of thyroid cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
